Alkem Laboratories Financial Statements

Alkem Laboratories Cash Flow

Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2018 Mar-2017
Growth matrix (%)        
Revenue growth 6.24 29.90 12.90 15.50
Op profit growth 31.80 43.30 2.95 17.10
EBIT growth 43.50 35 (2.80) 1.01
Net profit growth 40.60 78.60 (29) 20.30
Profitability ratios (%)        
OPM 21.90 17.70 16 17.60
EBIT margin 21.40 15.90 15.30 17.80
Net profit margin 17.90 13.50 9.82 15.70
RoCE 21.70 18.40 16.70 20.10
RoNW 5.85 5.11 3.38 5.47
RoA 4.52 3.92 2.69 4.44
Per share ratios ()        
EPS 135 96.10 53.40 74.50
Dividend per share 30 25 13 15
Cash EPS 110 73.10 40.80 66.10
Book value per share 617 515 407 374
Valuation ratios        
P/E 20.50 24.20 37 29.60
P/CEPS 25.30 31.80 48.40 33.40
P/B 4.49 4.52 4.86 5.91
EV/EBIDTA 15.10 18 21.40 24
Payout (%)        
Dividend payout -- -- 24.60 9.68
Tax payout (12) (8.80) (31) (6.20)
Liquidity ratios        
Debtor days 67 59.70 51 41.10
Inventory days 85 71.30 75.30 67.90
Creditor days (53) (51) (58) (51)
Leverage ratios        
Interest coverage (32) (20) (18) (22)
Net debt / equity -- 0.08 0.09 0.06
Net debt / op. profit (0.10) 0.36 0.41 0.26
Cost breakup ()        
Material costs (39) (40) (39) (39)
Employee costs (18) (18) (19) (18)
Other costs (20) (24) (26) (26)
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Revenue 8,865 8,344 6,422 5,688
yoy growth (%) 6.24 29.90 12.90 15.50
Raw materials (3,498) (3,345) (2,513) (2,222)
As % of sales 39.50 40.10 39.10 39.10
Employee costs (1,621) (1,505) (1,192) (1,004)
As % of sales 18.30 18 18.60 17.70
Other costs (1,803) (2,021) (1,689) (1,463)
As % of sales 20.30 24.20 26.30 25.70
Operating profit 1,942 1,473 1,028 999
OPM 21.90 17.70 16 17.60
Depreciation (275) (253) (143) (101)
Interest expense (59) (65) (55) (45)
Other income 233 104 96 112
Profit before tax 1,842 1,260 926 965
Taxes (224) (110) (288) (60)
Tax rate (12) (8.80) (31) (6.20)
Minorities and other (33) (22) (7.50) (13)
Adj. profit 1,585 1,127 631 892
Exceptional items -- -- -- --
Net profit 1,585 1,127 631 892
yoy growth (%) 40.60 78.60 (29) 20.30
NPM 17.90 13.50 9.82 15.70
Switch to
Tabular Data
Graph
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2018 Mar-2017
Profit before tax 1,842 1,260 926 965
Depreciation (275) (253) (143) (101)
Tax paid (224) (110) (288) (60)
Working capital 1,186 1,482 739 (79)
Other operating items -- -- -- --
Operating cashflow 2,529 2,378 1,235 724
Capital expenditure 162 1,003 627 439
Free cash flow 2,691 3,382 1,861 1,163
Equity raised 11,905 9,850 8,808 7,291
Investments 71.40 (183) (109) 44.40
Debt financing/disposal 2,054 1,509 883 564
Dividends paid -- -- 155 71.70
Other items -- -- -- --
Net in cash 16,721 14,557 11,599 9,134
Switch to
Tabular Data
Graph
Switch to
Consolidated
Standalone
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2019 Mar-2018
Equity capital 23.90 23.90 23.90 23.90
Preference capital -- -- -- --
Reserves 7,353 6,137 5,415 4,840
Net worth 7,377 6,161 5,439 4,864
Minority interest
Debt 1,707 1,616 944 998
Deferred tax liabilities (net) 174 167 359 311
Total liabilities 9,439 8,092 6,875 6,294
Fixed assets 3,186 3,271 3,023 2,665
Intangible assets
Investments 333 261 324 444
Deferred tax asset (net) 1,282 1,100 1,066 965
Net working capital 2,648 2,367 1,800 1,643
Inventories 2,312 1,819 1,500 1,442
Inventory Days 95.20 79.60 -- 82
Sundry debtors 1,607 1,649 1,248 1,081
Debtor days 66.20 72.10 -- 61.40
Other current assets 982 920 744 802
Sundry creditors (1,069) (954) (962) (961)
Creditor days 44 41.70 -- 54.60
Other current liabilities (1,185) (1,067) (730) (720)
Cash 1,990 1,092 662 577
Total assets 9,439 8,092 6,875 6,294
Switch to
Consolidated
Standalone


Particulars ( Rupees In Crores.) Mar-2021 Dec-2020 Sep-2020 Jun-2020 Mar-2020
Gross Sales 2,192 2,318 2,363 2,003 2,049
Excise Duty -- -- -- -- --
Net Sales 2,192 2,318 2,363 2,003 2,049
Other Operating Income -- -- -- -- --
Other Income 46.30 96.40 35.50 43.50 27.50
Total Income 2,238 2,414 2,398 2,047 2,076
Total Expenditure ** 1,901 1,789 1,762 1,470 1,746
PBIDT 337 626 636 577 331
Interest 10.70 13.10 18 17.10 14.20
PBDT 327 612 618 560 316
Depreciation 68.50 69 70.20 66.80 81.10
Minority Interest Before NP -- -- -- -- --
Tax 81.10 101 114 100 143
Deferred Tax (72) (22) (48) (31) (99)
Reported Profit After Tax 249 464 482 423 192
Minority Interest After NP 9.23 12.90 9.45 1.18 2.77
Net Profit after Minority Interest 240 451 472 422 189
Extra-ordinary Items -- -- -- -- --
Adjusted Profit After Extra-ordinary item 240 451 472 422 189
EPS (Unit Curr.) 20.10 37.70 39.50 35.30 15.80
Book Value (Unit Curr.) -- -- -- -- --
Dividend (%) -- 1,250 -- -- --
Equity 23.90 23.90 23.90 23.90 23.90
Public Shareholding (Number) -- -- -- -- --
Public Shareholding (%) -- -- -- -- --
Pledged/Encumbered - No. of Shares -- -- -- -- --
Pledged/Encumbered - % in Total Promoters Holding -- -- -- -- --
Pledged/Encumbered - % in Total Equity -- -- -- -- --
Non Encumbered - No. of Shares -- -- -- -- --
Non Encumbered - % in Total Promoters Holding -- -- -- -- --
Non Encumbered - % in Total Equity -- -- -- -- --
PBIDTM(%) 15.40 27 26.90 28.80 16.10
PBDTM(%) 14.90 26.40 26.20 27.90 15.40
PATM(%) 11.40 20 20.40 21.10 9.35
Open ZERO Brokerage Demat Account